EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Drug Insight: bleeding after percutaneous coronary intervention-risks, measures and impact of anticoagulant treatment options

Martin T Rothman

Nature Clinical Practice Cardiovascular Medicine · 2005-09 · 2 (9) · 465-474

DOI: 10.1038/ncpcardio0311 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nature Clinical Practice Cardiovascular Medicine, 2005-09. Verfasst von Martin T Rothman. Beteiligte Einrichtung: London Chest Hospital, Barts, UK. martin.rothman@bartsandthelondon.nhs.uk. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 61 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Age FactorsAngioplasty, Balloon, CoronaryAnticoagulantsAntithrombinsHemorrhageHospital CostsHumansPlatelet Aggregation InhibitorsRisk FactorsTreatment Outcome

Substanzen

AnticoagulantsAntithrombinsPlatelet Aggregation Inhibitors

Autor:innen und Institutionen

  • London Chest Hospital, Barts, UK. martin.rothman@bartsandthelondon.nhs.uk

Zitieren

APA

Rothman, M. T. (2005). Drug Insight: bleeding after percutaneous coronary intervention-risks, measures and impact of anticoagulant treatment options. Nature Clinical Practice Cardiovascular Medicine, 2(9), 465-474. https://doi.org/10.1038/ncpcardio0311

Vancouver

Rothman MT. Drug Insight: bleeding after percutaneous coronary intervention-risks, measures and impact of anticoagulant treatment options. Nature Clinical Practice Cardiovascular Medicine. 2005;2(9):465-474. doi:10.1038/ncpcardio0311

BibTeX
@article{Rothman2005,
  author = {Rothman, Martin T},
  title = {Drug Insight: bleeding after percutaneous coronary intervention-risks, measures and impact of anticoagulant treatment options},
  journal = {Nature Clinical Practice Cardiovascular Medicine},
  year = {2005},
  volume = {2},
  number = {9},
  pages = {465--474},
  doi = {10.1038/ncpcardio0311}
}
Kostenlos starten →